Clinical trial
Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic…
NCT00388219 · Grünenthal GmbH, Industry · Terminated
Key facts
| NCT number | NCT00388219 |
|---|---|
| Title | Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations |
| Official title | Single Dose Bioequivalence Trial Comparing a New Analgesic Transdermal Patch Formulation to an Analgesic Reference Patch |
| Lead sponsor | Grünenthal GmbH, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Transtec (R) PRO (buprenorphine) |
| Enrollment | 24 |
| Start date | Oct 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Oct 16, 2006 |
| Last update posted | Jul 6, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: